Your browser version may not work well with NCBI's Web applications. More information here...
1: Rinsho Ketsueki. 2003 Jul;44(7):471-3.Links

[Allergic reaction against an emulsifier, HCO-60, contained in multamin and enocitabine]

[Article in Japanese]

Tatetsu H, Asou N, Nakamura M, Koh Y, Tajiri T, Matsuno F, Horikawa K, Yonemura Y, Mitsuya H.

Department of Internal Medicine II, Kumamoto University School of Medicine.

We report two cases of an allergic reaction to HCO-60, which is used as an emulsifien for Multamin and enocitabine. A 55-year-old woman with M 4 Eo developed a high fever, urticaria and erythema after induction chemotherapy. After stopping the administration of Multamin, her fever and eruptions subsided. A 51-year-old woman with L 2 developed erythema and hypotension 30 minutes after the third administration of Multamin. When the patient was given enocitabine, she developed anaphylactic shock. During chemotherapy in patients with leukemia, it is important to distinguish the allergic reaction against Multamin-containing HCO-60 from infection and allergies to other drugs.

PMID: 12931567 [PubMed - indexed for MEDLINE]

Patient Drug Information

  • Cytarabine (Cytosar-U® , DepoCyt® )

    Your doctor has ordered the drug cytarabine to help treat your illness. The drug can be given by injection into a vein or under the skin of your forearm. In special situations, it may be injected into the spinal cord.

  • Source: AHFS Consumer Medication Information